Companion Diagnostics
Commercialization of precision diagnostics
We offer a flexible model for support of precision diagnostic that can be modulated to fit the needs of the different markets for support.
When developing new precision diagnostic tests, the Dx/Rx partnership is a well-established paradigm. We propose the addition of the Lx, the laboratory CRO.
What we offer
- A rich toolbox of CDx-relevant technology
- An exceptional menu of services supporting clinical trials, diagnostic development and commercialisation
- Intimate knowledge of local testing standards and regulatory requirements
- Speed and efficiency in method development and transfer
- Competence in navigating logistical challenges throughout Europe and North America
- With more than 210 laboratories in 15 European countries we can support market access of both central and localized testing of new precision diagnostic tests into European market.
![Lx](/sites/default/files/2019-04/CDx%20-%20Lx.png)
Europe’s leading CDx provider
Our end-to-end Service Model
Overview of our services